Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Panitumumab Drug Information

A healthcare provider may prescribe panitumumab (Vectibix®) to help slow down progression of colorectal cancer that has spread to other areas of the body despite other chemotherapy treatment.
Panitumumab works by binding to a certain receptor, known as the epidermal growth factor receptor (EGFR), found on the surface of certain cancer cells. By binding to EGFR, panitumumab slows down the growth of cancer cells.
 
Panitumumab comes as a liquid that is administered intravenously (though an IV) every 14 days. Although it may be an effective medication, not everyone can use this drug. Information on panitumumab should be reviewed with your healthcare provider before starting treatment to help ensure a safe treatment. For instance, you may not be able to use this medicine if you are taking certain medications or have lung disease.
 
(Click Panitumumab for more information on this drug, including how it performed in clinical trials and other issues to discuss with your healthcare provider before starting treatment.)
 

Panitumumab Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.